(Press-News.org) PHILADELPHIA — An increasing body mass index was associated with a higher risk for colorectal cancer with a specific molecular characteristic, and inversely, physical activity was linked to a decreased risk for that same cancer, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
"We know that exercise and avoiding obesity decrease colorectal cancer risk, but little is known about why," said Shuji Ogino, M.D., Ph.D., associate professor of pathology at Dana-Farber Cancer Institute and associate professor in the Department of Epidemiology at Harvard School of Public Health in Boston, Mass. "In this study, we used a biomarker named CTNNB1, which is a molecule implicated in cancer and obesity, to divide patients into two groups, CTNNB1-positive and CTNNB1-negative."
Ogino and colleagues used data from more than 100,000 women from the Nurses' Health Study and more than 45,000 men in the Health Professionals Study to examine whether there was an association between body mass index (BMI) or exercise activity and colorectal cancer risk according to CTNNB1 expression status.
Among the study population, 2,263 individuals were diagnosed with colorectal cancer during follow-up. Tumor CTNNB1 expression data were available for 861 of these individuals, and 54 percent of these tumors were negative for CTNNB1 and 46 percent positive for the biomarker.
Increasing BMI by a 5.0 kg/m2 increment was associated with a 34 percent higher risk for CTNNB1-negative cancer, but was not associated with CTNNB1-positive cancer. In contrast, increasing physical activity level was associated with a significantly lower risk for CTNNB1-negative cancer. It was not associated with CTNNB1-positive cancer.
"Our results provide additional evidence for a causal role of obesity and a physically inactive lifestyle in a specific molecular subtype of colorectal cancer," Ogino said. "If physicians are able to identify individuals who are prone to develop CTNNB1-negative cancer, then it would be possible to strongly recommend physical activity."
In addition, the data indicated that CTNNB1 could be a potential target for chemoprevention and treatment, according to Ogino. He called for more population-based, large-scale databases to facilitate molecular pathological epidemiology research.
"Currently, most population-based studies do not take tumor heterogeneity into consideration, and typically colon cancer is treated as a single disease," Ogino said. "We need to integrate molecular pathology and epidemiology in education and research to facilitate integrative science and improve public health."
###
Follow the AACR on Twitter: @aacr -
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world's first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the scientific partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit www.AACR.org.
Obesity, physical inactivity linked with risk for certain molecular subtype of colorectal cancer
2013-02-27
ELSE PRESS RELEASES FROM THIS DATE:
Over a million pregnant women infected with syphilis world-wide
2013-02-27
Syphilis still affects large numbers of pregnant women world-wide, causing serious health problems and even death to their babies, yet this infection could be prevented by early testing and treatment, according to a study by international researchers published in this week's PLOS Medicine.
Researchers, led by Lori Newman from the World Health Organization, estimate that in 2008, 1.4 million pregnant women around the world were infected with syphilis, 80% of whom had attended antenatal care services.
The researchers reached this figure by using information on the number ...
U-M study challenges notion of using Herceptin only for HER2-positive breast cancer
2013-02-27
ANN ARBOR, Mich. — New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative – and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.
About 20 percent of women with breast cancer have tumors labeled HER2-positive. And since the drug Herceptin has come on the scene, it has had a tremendous impact on survival for these women, particularly when it is given in the ...
Study finds small increase in incidence of advanced breast cancer among younger women
2013-02-27
An analysis of breast cancer trends in the U.S. finds a small but statistically significant increase in the incidence of advanced breast cancer for women 25 to 39 years of age, without a corresponding increase in older women, according to a study appearing in the February 27 issue of JAMA.
"In the United States, breast cancer is the most common malignant tumor in adolescent and young adult women 15 to 39 years of age, accounting for 14 percent of all cancer in men and women in the age group. The individual average risk of a woman developing breast cancer in the United ...
Bariatric surgery complications rates following restricting coverage to higher-quality centers
2013-02-27
In an analysis of data on patients who underwent bariatric surgery 2004-2009, there was no significant difference in the rates of complications and reoperation for Medicare patients before vs. after a 2006 Centers for Medicare & Medicaid Services policy that restricted coverage of bariatric surgery to centers of excellence, according to a study appearing in the February 27 issue of JAMA.
"Prompted by concerns about perioperative safety with bariatric surgery, the Centers for Medicare & Medicaid Services (CMS) issued a national coverage decision in 2006 that limited coverage ...
Frequency of surveillance scans for small aneurysms can be reduced for most patients
2013-02-27
In contrast to the commonly adopted surveillance intervals in current abdominal aortic aneurysm (AAA) screening programs, surveillance intervals of several years may be clinically acceptable for the majority of patients with small AAA, as the smallest AAAs often do not appear to change significantly over many years, according to a meta-analysis of previous studies reported in the February 27 issue of JAMA.
"The survival rate following rupture of an abdominal aortic aneurysm is only 20 percent, making AAAs an important cause of mortality," according to background information ...
Long-term use of medication does not improve symptoms for heart failure patients
2013-02-27
Among patients with heart failure with preserved ejection fraction, long-term treatment with the medication spironolactone improved left ventricular diastolic function but did not affect maximal exercise capacity, patient symptoms, or quality of life, according to a study appearing in the February 27 issue of JAMA.
"Heart failure (HF) with preserved ejection fraction [EF; the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat is 50 percent or greater] accounts for more than 50 percent of the total HF population," according to background ...
Simple method devised for determining atrial fibrillation risk in women
2013-02-27
Boston - Atrial fibrillation is the most common type of abnormal heart rhythm, affecting 2.5 million Americans. If left undetected or untreated, atrial fibrillation can lead to stroke. Determining who is at increased risk for atrial fibrillation has been difficult, especially among individuals without established heart disease. But now, researchers from Brigham and Women's Hospital have devised and tested a simple atrial fibrillation risk prediction model, based on six easily obtained factors: a woman's age, height, weight, blood pressure, alcohol consumption and smoking ...
Just a drop? Alcohol consumption much higher than reported in England
2013-02-27
Alcohol consumption could be much higher than previously thought, with more than three quarters of people in England drinking in excess of the recommended daily alcohol limit, according to a new paper in the European Journal of Public Health. The study, conducted by researchers in the UCL Department of Epidemiology and Public Health, is the first to investigate the potential public health implications related to the under-reporting of alcohol consumption.
International studies have shown that self-reported alcohol consumption only accounts for between 40 and 60 per cent ...
New tool in the fight against tropical diseases
2013-02-27
A novel tool exploits baker's yeast to expedite the development of new drugs to fight multiple tropical diseases, including malaria, schistosomiasis, and African sleeping sickness. The unique screening method uses yeasts which have been genetically engineered to express parasite and human proteins to identify chemical compounds that target disease-causing parasites but do not affect their human hosts.
Parasitic diseases affect millions of people annually, often in the most deprived parts of the world. Every year, malaria alone infects over 200 million people, killing ...
HPS2-THRIVE trial: Side-effects cause a quarter of heart patients to stop treatment
2013-02-27
The largest randomised study of the vitamin niacin in patients with occlusive arterial disease (narrowing of the arteries) has shown a significant increase in adverse side-effects when it is combined with statin treatment.
Results from the HPS2-THRIVE study (Heart Protection Study 2 – Treatment of HDL to Reduce the Incidence of Vascular Events), including the reasons patients stopped the study treatment, are published online today (Wednesday) in the European Heart Journal [1].
Niacin has been used for decades to help increase levels of "good" HDL cholesterol and to ...